Doctor profile · Federal record
Dr. Allison Loftus
Physician Assistant · Overland Park, KS
- NPI 1497222541
- Accepts Medicare
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10701 Nall Ave Ste 100
Overland Park, KS 662111244
(913) 338-5585
fax (913) 338-3228
Credentials & registration
- NPI registered
- October 2018 — 8 yrs on file
- Profile last updated
- August 12, 2025
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1497222541. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,772
Distinct HCPCS
9
Medicare allowed
$290,726
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 4,740 | 42 | $23 | |
J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg | 654 | 158 | $168 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 551 | 352 | $101 | |
96402 |
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 212 | 160 | $26 | |
84153 |
Psa (prostate specific antigen) measurement, total | 145 | 112 | $18 | |
84403 |
Testosterone (hormone) level, total | 145 | 110 | $25 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 139 | 108 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 135 | 105 | $10 | |
96372 |
Injection of drug or substance under skin or into muscle | 51 | 43 | $11 |
In context: peer comparison
Among 26 peers in Overland Park Physician Assistant, average services per provider: 155. This provider delivers 44× the peer median.Open Payments
Industry payments received
All-time total
$1,633
Transactions
84
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 7 | $232.76 | |
| Pfizer INC. | 20 | $171.60 | |
| Dendreon Pharmaceuticals LLC | 6 | $153.39 | |
| Abbvie INC. | 11 | $139.67 | |
| Novartis Pharmaceuticals Corporation | 12 | $134.23 | |
| Astellas Pharma US INC | 5 | $118.41 | |
| Merck Sharp & Dohme LLC | 4 | $105.24 | |
| Progenics Pharmaceuticals, INC. | 4 | $98.76 | |
| Bayer Healthcare Pharmaceuticals INC. | 3 | $87.61 | |
| Sumitomo Pharma America, INC. | 3 | $56.33 | |
| Becton, Dickinson and Company | 2 | $46.70 | |
| Sun Pharmaceutical Industries INC. | 2 | $44.83 | |
| Tolmar, INC. | 2 | $43.78 | |
| Urogen Pharma, INC. | 1 | $40.41 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $38.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
674
Patients
163
Total drug cost
$2,017,955
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 127 | 36 | $1,122 |
| Abiraterone Acetate | Generic | 95 | 22 | $175,388 |
| Venlafaxine Hcl | Generic | 78 | 22 | $1,284 |
| Xtandi (Enzalutamide) | Brand | 66 | 11 | $631,049 |
| Bicalutamide | Generic | 65 | 44 | $1,287 |
| Nubeqa (Darolutamide) | Brand | 44 | 0 | $627,824 |
| Alendronate Sodium | Generic | 37 | 28 | $455 |
| Erleada (Apalutamide) | Brand | 34 | 0 | $512,249 |
| Potassium Chloride | Generic | 33 | 0 | $462 |
| Megestrol Acetate | Generic | 28 | 0 | $743 |
Hospital affiliations
Frequently asked questions
What is Dr. Allison Loftus's medical specialty?
Dr. Allison Loftus practices Physician Assistant in Overland Park, KS.
Where does Dr. Allison Loftus practice?
Dr. Allison Loftus practices at 10701 Nall Ave Ste 100, Overland Park, KS 662111244. Office phone: 9133385585.
What is Dr. Allison Loftus's NPI?
Dr. Allison Loftus's National Provider Identifier (NPI) is 1497222541, issued by NPPES.
Does Dr. Allison Loftus accept Medicare assignment?
Yes. Dr. Allison Loftus accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Allison Loftus commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS J9217); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.